1.
|
Phase: Phase III Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: D4320C00014, 2007-003227-20, NCT00554229
|
|
2.
|
Phase: Phase III Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: D4320C00033, NCT00617669
|
|
3.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 4054IL/0004, NCT00055471
|
|
4.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: D4320C00035, NCT00745875
|
|
5.
|
Phase: Phase II Type: Treatment Status: Enrolling by invitation Age: 18 to 90 Sponsor: Other Protocol IDs: ISSIS40540005, DAPROCA-1, NCT01000948
|
|
6.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: CO09805, NCT01119118
|
|
7.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: D4320C00020, 4054IL/0020, NCT00314782
|
|
8.
|
Phase: Phase I Type: Treatment Status: Completed Age: 50 and over Sponsor: Pharmaceutical / Industry Protocol IDs: D4320C00041, NCT00997945
|